transcosmos Releases Chat Platform “DECAds Chat Edition”

Tokyo, Japan (PRWEB) April 28, 2017

transcosmos inc. announced that the company released a chat platform, “DECAds Chat Edition”.

“DECAds Chat Edition” is a contact center operations platform which supports One to One communications between clients and their customers via chat, leveraging various social media, websites and business apps. The platform helps businesses to boost customer engagement by actively communicating with the customers through the entire customer journey from marketing, sales to customer support in real-time, while making the communication highly efficient, capitalizing on the chatbot auto-response. “DECAds Chat Edition” also supports LINE Customer Connect, a customer support service for businesses by LINE.

The platform is equipped with real-time monitoring and reporting features on the operator admin page. “DECAds Chat Edition”, a cloud-based service, is highly customizable, offering diverse services by linking to the clients’ systems including their billing and core system.

  • “DECAds Chat Edition” – Key features

1. Supports multiple customer entry points

Offers chat service via multiple customer entry points simultaneously, including messaging apps and web browsers

2. Chatbot auto-response

Relays received customer inquiries from chatbot auto-response to human operators as needed

3. Full-scale support for operators

Ensures efficient chat-operations, providing management features such as KPI and log management
transcosmos has formed capital and business alliance with Mobilus Corporation (Headquarters: Tokyo, Japan; CEO: Tomohiro Ishii) and received OEM products to develop “DECAds Chat Edition”. transcosmos plans to add unique features on the platform going forward.

  • transcosmos’s “DEC” Services

transcosmos has integrated Digital Marketing, E-Commerce and Contact Center functions into “DEC”, taking the initial letter of each, in order to accommodate the changes in consumer behaviors in this digital world. So far, we have developed and offer two “DEC” services, “DECode” – DMP service – and “DECAds” – chat-ads menu. Now, we offer “DECAds Chat Edition” as a chat feature of “DECAds” as well as one of the services of “DECAds” series which delivers comprehensive service from ads to customer support.

transcosmos continues to proactively propose innovative one-stop operational services to attract customers, expand sales and to support customers, while actively developing the new services for businesses.

  • transcosmos’s Initiatives on Chat Services

transcosmos launched “Social media operations services” in May, 2011, serving over 100 clients by leveraging Shibuya Social Media Center and its call centers located across Japan. Many businesses demand robust monitoring structure for their social media operations to oversee operational framework, secure governance, manage risk as well as to have coherent marketing activities. At the same time, businesses demand the service providers to actively come up with proposals to keep up with the digitalized consumers. By connecting consumer communication with ads, transcosmos delivers the right message about the clients’ services to broader audiences.

  • About “LINE Customer Connect”

LINE Customer Connect helps businesses deliver the right customer experience, understanding the individual customer needs in context and seamlessly combining various communication channels including voice, AI and human operator chat services on LINE at contact centers.

  • transcosmos is a trademark or registered trademark of transcosmos inc. in Japan and other countries.
  • Other company names and product or service names used here are trademarks or registered trademarks of respective companies.

About Mobilus Corporation

Mobilus develops and sells chat tools as well as supplies OEM products for customer centers and customer service functions that leverage both auto-response and human operators. Its “mobi AGENT”, a chat tool optimized for contact center operations with real-time monitoring and reporting features, allows businesses to centrally manage chat inquiries by connecting the tool with their websites, original apps, SNS and other multiple channels. Integrating chatbot auto-response with human operators, “mobi AGENT” supports customers seamlessly, leveraging various AI (artificial intelligence), CRM and FAQ systems. (URL:

About transcosmos inc.

transcosmos launched its operations in 1966. Since then, we have combined superior “people” with up-to-date “technology” to enhance the competitive strength of our clients by providing them with superior and valuable services. transcosmos currently offers services that support clients’ business processes focusing on both sales expansion and cost reduction through our 171 locations across 31 countries with a focus in Asia, while continuously pursuing Operational Excellence. Furthermore, following the expansion of e-commerce market on the global scale, transcosmos provides a comprehensive One-Stop Global E-Commerce Services to deliver our clients' excellent products and services to consumers in 49 countries around the globe. transcosmos aims to be the “Global Digital Transformation Partner” of our clients, supporting the clients’ transformation by leveraging digital technology, responding to the ever changing business environment.

Read the full story at

Dr. Maura Marks Touts the Merits of Modern Hearing Aids

Boston, MA (PRWEB) April 28, 2017

People are starting to accept that hearing aids can be helpful and are not just for older people. “Wearing a hearing aid doesn’t have the stigma it had when great-grandpa wore his hearing aids years ago,” said Dr. Maura Marks, founder of Speech-Language & Hearing Associates of Greater Boston, in a NALA North American Speaker Series (NASS) segment. “He probably wore an iPod-size hearing aid on his body with wires running down from his ears. We have really come a long way since those days. The devices worn were large to accommodate the large batteries and transistors inside.”

In fact, thanks to computer technology, hearing aids today are much smaller and more stylish, and most are not even visible. However, there are still other misconceptions about hearing aids. For example, people tend to focus on price and assume the best place to go is one of the big box stores.

“Many people don’t realize that hearing aids may require reprogramming and other adjustments, as well as repairs,” noted Dr. Marks. “Consumers should look to develop a relationship with a hearing healthcare professional because you will probably have that hearing aid for around 3-5 years. Think about your desk or laptop computer and how many times you’ve required support or service over the same period of time. Another important consideration is that hearing loss needs to be monitored over time, which may require that adjustments be made to the hearing aid fitting.”

Research supports the “use or lose it” concept for hearing and mental activity. People with hearing loss who haven’t worn hearing aids may develop inaccuracies in their speech. “This is because we monitor our speech through our hearing,” added Dr. Marks. “Hearing loss is also associated with social isolation and the tendency to tune out. In fact, hearing aids are being considered as an early treatment for cognitive decline and Alzheimer’s disease.”

At Speech-Language & Hearing Associates of Greater Boston, a speech language and hearing center, Dr. Marks and her staff treat patients with a variety of disorders, some very complex. They monitor children who have chronic middle ear problems for speech and language delays. They also treat post-stroke patients who are having difficulty hearing and Parkinson’s patients receiving speech therapy for improving voice volume, a characteristic of Parkinson’s disease, who may also need a hearing aid.

“We have also noticed a concern by millennials about their hearing. We recently fit hearing aids on a younger gentleman who noticed he was having difficulty understanding speech in competing noise and he loves them,” concluded Dr. Marks. “Improvements in hearing aid technology provide greater clarity for listening in background noise and can offer custom programming for a variety of daily listening situations.”

To listen to Dr. Marks’ NASS segment in its entirety, please visit The NALA’s NASS gives small and medium-sized business owners a unique platform to present their stories and industry expertise to a diverse, hyper-local audience through short, poignant audio segments.

About Speech-Language & Hearing Associates of Greater Boston

Speech-Language & Hearing Associates of Greater Boston was founded by Dr. Maura Marks, Ph.D., Au.D. It has been providing diagnostic and therapeutic services to the Boston and Metro West communities for more than 16 years. Dr. Marks is among a small group of professionals with two doctoral degrees and dually certified in both Speech-Language Pathology and Audiology. For more information, please call (508) 359-4532, or visit

About the NALA™

The NALA offers small and medium-sized businesses effective ways to reach customers through new media. As a single-agency source, the NALA helps businesses flourish in their local community. The NALA’s mission is to promote a business’ relevant and newsworthy events and achievements, both online and through traditional media. For media inquiries, please call 805.650.6121, ext. 361.

Read the full story at

Christie Medical Holdings, Inc., & B. Braun Medical Announce Collaboration Aimed at Improving Peripheral IV Access Success

MEMPHIS, Tenn. (PRWEB) April 28, 2017

Christie Medical Holdings, Inc., with its market-leading vein finder technology, VeinViewer® system, today announced an alliance with B. Braun Medical Inc., a leader in infusion therapy and pain management.

Intravenous (IV) therapy plays a central role in patient care with as many as 90 percent of hospital patients receiving a peripheral IV catheter as part of their treatment plan. Many hospitals are adopting technology to improve the placement, safety, and duration for peripheral IV access. The combination of VeinViewer by Christie and B. Braun Medical’s line of IV products – such as the Introcan Safety® IV catheter, STEADYCare™ extension set with Wedge™ catheter stabilizer – aims to provide an innovative solution to enhance peripheral IV catheter access success.

“Aligning the VeinViewer technology with one of the top companies in the United States’ peripheral IV catheter market provides our customers with a seamless solution for improving peripheral IV access,” said George Pinho, president of Christie Medical Holdings. “B. Braun’s extensive coverage across the U.S. hospital market and excellent reputation will enable us to work together to serve more customers with VeinViewer and the Introcan Safety IV Catheter. More importantly, health care providers and patients will be the primary beneficiaries of this strategic alliance.”

VeinViewer reduces the time needed for IV insertion and improves first stick success when starting an IV catheter, ultimately improving the patient experience. VeinViewer allows nurses to clearly see peripheral veins as a real-time, high-definition image directly on the surface of the patient’s skin. With VeinViewer technology, hospitals recognize the benefit of increased success in obtaining peripheral IV access, reduced use of central lines and increased cost savings.

B. Braun's Introcan Safety IV catheter complements the VeinViewer system, because it offers passive safety through an innovative solution that addresses accidental needlestick injury.

Additionally, B. Braun’s STEADYCare extension set with Wedge catheter stabilizer is designed to minimize catheter movement in the vessel, support the catheter insertion angle, and reduce the patient connector's skin contact, helping to reduce catheter-related complications.

“These technologies are intended to work together to improve placement, insertion, duration and safety associated with peripheral IV catheter therapy,” said Tom Sutton, B. Braun Medical’s Vice President of Marketing for IV Systems, Vascular Access and Pharmacy Admixture Products. "The VeinViewer technology is an excellent addition to our infusion therapy product line, because it addresses the first critical step in peripheral IV therapy success by helping the clinician select the best vein for placing an IV catheter. Our hospital customers are seeking solutions to improve the patient experience associated with peripheral IV access. This collaboration helps us achieve that.”

As part of the alliance, B. Braun and Christie will focus on bringing VeinViewer to all hospitals in the United States. B. Braun will be the exclusive distributor of VeinViewer in the United States. Christie will continue to sell VeinViewer to Veterans Affairs hospitals, outpatient facilities, vein clinics, and educational centers, such as nursing schools. Christie also will continue to manage its international distribution partners.

All VeinViewer customers — regardless of where they buy their VeinViewer — will continue to receive service through Christie. Additionally, Christie will continue offering educational programs as described in the Christie Assure Program™, including Christie University, tele-training and Assure Clinical Educators.

  • VeinViewer is a registered trademark of Christie Medical Holdings, Inc.

About Christie Medical Holdings, Inc.

Christie Medical Holdings, Inc. is a global company based in Memphis, Tenn., that discovers, develops and commercializes medical technologies. The company’s market-leading product, VeinViewer, is manufactured in the USA. It is a mobile vein imaging system that allows health care providers to clearly see accessible peripheral veins as a real time HD image, directly on the surface of the skin. Christie Medical Holdings, Inc. is owned by Christie Digital Systems Inc., a global visual technologies company and a subsidiary of Ushio Inc., Japan (JP:6925). For more information on Christie Digital Systems or Christie Medical Holdings, Inc., visit

About B. Braun

B. Braun Medical Inc., a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the health care industry. The company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. B. Braun Medical is part of the B. Braun Group of Companies in the U.S., which is headquartered in Bethlehem, PA., and includes B. Braun Interventional Systems, Aesculap® and CAPS®.

Globally, the B. Braun Group of Companies employs more than 58,000 employees in 64 countries. Guided by its Sharing Expertise® philosophy, B. Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs. To learn more about B. Braun Medical, visit

Follow us on Twitter @veinviewer

Facebook: VeinViewer

Read the full story at